Morepen Laboratories Gains 13.99%: 8 Key Factors Driving the Surge

2 hours ago
share
Share Via
Morepen Laboratories Ltd delivered a strong weekly performance from 17 to 21 August 2026, gaining 13.99% to close at Rs.96.00, significantly outperforming the Sensex which declined 0.40% over the same period. The stock hit multiple new 52-week highs during the week, supported by exceptional volume surges, positive technical indicators, and an upgraded Mojo Grade to Hold, signalling renewed investor confidence amid a mixed broader market environment.

Key Events This Week

17 Aug: New 52-week high (Rs.86.88)

18 Aug: New 52-week high (Rs.92.44)

20 Aug: Intraday high surge and new 52-week high (Rs.94.8)

21 Aug: New 52-week high close at Rs.97.46

Week Open
Rs.84.22
Week Close
Rs.96.00
+13.99%
Week High
Rs.97.46
Sensex Change
-0.40%

17 August 2026: Momentum Builds with New 52-Week High and Volume Surge

Morepen Laboratories Ltd began the week on a strong note, hitting a new 52-week high of Rs.86.88 on 17 August 2026. The stock closed at Rs.89.83, up 6.66% on the day, significantly outperforming the Sensex which declined 0.15%. This surge was accompanied by exceptional trading volume of nearly 3 million shares, with delivery volumes rising sharply, indicating genuine accumulation rather than speculative trading.

Technical indicators were supportive, with the stock trading above all key moving averages and bullish signals from MACD and Bollinger Bands. The stock outperformed its Pharmaceuticals & Biotechnology sector by 2.91%, reflecting strong sector-relative strength amid a subdued market.

18 August 2026: Continued Rally with New Highs and Sustained Volume

On 18 August, Morepen Laboratories extended its rally, touching a new 52-week high of Rs.92.44 and closing at Rs.88.36, a slight dip of 1.64% intraday but still maintaining gains from prior sessions. The stock outperformed its sector by 1.95% and traded with a robust volume of 1.29 crore shares, translating to a traded value of approximately ₹117.10 crores. Delivery volumes surged by over 77%, signalling strong investor confidence and accumulation.

Despite a broader market decline with Sensex down 0.43%, Morepen’s technical setup remained bullish, supported by positive momentum indicators and alignment above all major moving averages. The stock’s cumulative return over four days reached 24.76%, underscoring sustained buying interest.

Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!

  • - Sustainable profitability reached
  • - Post-turnaround strength
  • - Comeback story unfolding

Be Early to the Comeback →

20 August 2026: Intraday Surge and New 52-Week Highs Amidst Volume Spike

Morepen Laboratories Ltd delivered a standout performance on 20 August, surging 9.00% intraday to close at Rs.96.39. The stock reached an intraday high of Rs.94.8, marking an 8.27% gain from the previous close and setting a new 52-week high. This rally was supported by a significant volume surge of over 7.7 million shares, with a traded value exceeding ₹70 crores.

Despite a mixed market environment where the Sensex gained 0.63%, Morepen outperformed its sector by 4.64%. However, delivery volumes declined sharply by 66.95%, suggesting some speculative trading alongside accumulation. The stock remained above all key moving averages, with bullish MACD and Bollinger Bands confirming strong momentum.

Over the last two sessions, the stock delivered a cumulative return of 7.27%, reinforcing its robust upward trend and technical strength.

21 August 2026: New 52-Week High Close Caps Off Strong Week

On the final trading day of the week, Morepen Laboratories Ltd closed at a new 52-week high of Rs.97.46, up 0.27% on the day and outperforming its sector by 1.18%. The stock has now recorded gains for three consecutive days, delivering a cumulative return of 9.8% during this period. This marks a remarkable 191.4% increase from its 52-week low of Rs.33.44.

Technical indicators remain supportive, with the stock trading above all major moving averages and bullish signals from MACD, Bollinger Bands, and On-Balance Volume. The Relative Strength Index shows a neutral weekly stance but a bearish monthly signal, suggesting some caution over longer horizons. The broader market was mixed, with the Sensex trading near flat but remaining above its 50-day moving average.

Morepen Laboratories Ltd or something better? Our SwitchER feature analyzes this small-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Daily Price Performance: Morepen Laboratories vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-08-17 Rs.89.83 +6.66% 36,907.46 -0.15%
2026-08-18 Rs.88.36 -1.64% 36,749.23 -0.43%
2026-08-19 Rs.88.43 +0.08% 36,577.15 -0.47%
2026-08-20 Rs.96.39 +9.00% 36,808.42 +0.63%
2026-08-21 Rs.96.00 -0.40% 36,814.22 +0.02%

Key Takeaways

Strong Outperformance: Morepen Laboratories gained 13.99% over the week, vastly outperforming the Sensex’s 0.40% decline, highlighting its resilience and investor appeal amid a mixed market.

Multiple New 52-Week Highs: The stock set new highs on four separate days, culminating in a close at Rs.97.46, reflecting sustained bullish momentum.

Exceptional Volume and Delivery Trends: Significant volume surges accompanied price gains, with delivery volumes indicating genuine accumulation early in the week, though a sharp delivery volume drop on 20 August suggests some speculative trading.

Technical Strength: Consistent trading above all key moving averages and bullish signals from MACD, Bollinger Bands, and On-Balance Volume support the stock’s upward trend.

Mojo Grade Upgrade: The upgrade from Sell to Hold with a Mojo Score of 64.0 on 3 August 2026 reflects improving fundamentals and market perception, adding confidence to the stock’s outlook.

Cautionary Signals: The Relative Strength Index’s bearish monthly stance and the decline in delivery volumes on 20 August suggest investors should monitor for potential volatility or profit-taking.

Conclusion

Morepen Laboratories Ltd’s impressive 13.99% weekly gain, multiple new 52-week highs, and strong volume-backed rallies underscore a significant shift in market sentiment towards this small-cap pharmaceutical stock. Supported by positive technical indicators and an upgraded Mojo Grade, the stock has demonstrated robust momentum and relative strength against a cautious broader market backdrop. While some caution is warranted due to mixed delivery volume signals and monthly momentum indicators, the overall trend remains constructive. Investors and market watchers will likely continue to monitor Morepen Laboratories closely as it navigates this phase of heightened activity and price appreciation.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News